
Opinion|Videos|November 21, 2023
Unmet Needs in the Cervical Cancer Treatment Landscape
The panel discusses unmet needs in the treatment landscape for patients with cervical cancer and the importance of clinical trials.
Advertisement
Episodes in this series

Advertisement
Related to this article

Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17.

Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the gratitude of living beyond cancer.

The immunotherapy may allow some patients with a specific genetic subtype of rectal cancer to avoid surgery, radiation and chemotherapy.

In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the screening visit, but its 24% lower rate of cancers found between screenings was not statistically significant.

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed her care.

Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable in his own skin at 60.

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung cancer in the phase 1b FURTHER trial.
Advertisement
Advertisement
Trending on CURE
1
How a Cancer Survivor Learned to Stop Hiding His Surgical Scars
2
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Firmonertinib Shows Responses in Lung Cancer With EGFR PACC Mutations
5


